These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9572232)

  • 21. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis.
    Divasta AD; Laufer MR; Gordon CM
    J Pediatr Adolesc Gynecol; 2007 Oct; 20(5):293-7. PubMed ID: 17868896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.
    Crosignani PG; Luciano A; Ray A; Bergqvist A
    Hum Reprod; 2006 Jan; 21(1):248-56. PubMed ID: 16176939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain.
    Friedman AJ; Hornstein MD
    Fertil Steril; 1993 Aug; 60(2):236-41. PubMed ID: 8339817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group.
    Surrey ES
    Fertil Steril; 1999 Mar; 71(3):420-4. PubMed ID: 10065775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GnRHa for adhesion formation after uterine serosal injury in an euestrogenic milieu.
    Ergeneli MH; Kuscu E; Zeyneloglu HB; Haberal A; Erdogan M
    J Reprod Med; 2000 Jan; 45(1):35-8. PubMed ID: 10664945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
    Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
    Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic therapy resulted in pregnancy in premature ovarian failure.
    Ohsawa M; Wu MC; Masahashi T; Asai M; Narita O
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):64S-67S. PubMed ID: 2410842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of substitution hormonal therapy on the hemostasis system in the pathologic climacteric].
    Marchenko LA; Makatsariia AD; Barabanova EV
    Akush Ginekol (Mosk); 1986 May; (5):35-8. PubMed ID: 3017141
    [No Abstract]   [Full Text] [Related]  

  • 29. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum-soluble CD23 in patients with endometriosis and the effect of treatment with danazol and leuprolide acetate depot injection.
    Odukoya OA; Bansal A; Wilson AP; Weetman AP; Cooke ID
    Hum Reprod; 1995 Apr; 10(4):942-6. PubMed ID: 7650148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group.
    Agarwal SK; Hamrang C; Henzl MR; Judd HL
    J Reprod Med; 1997 Jul; 42(7):413-23. PubMed ID: 9252932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study.
    Vercellini P; Bracco B; Mosconi P; Roberto A; Alberico D; Dhouha D; Somigliana E
    Fertil Steril; 2016 Mar; 105(3):734-743.e3. PubMed ID: 26677792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain.
    Bedaiwy MA; Casper RF
    Fertil Steril; 2006 Jul; 86(1):220-2. PubMed ID: 16716325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results.
    Wheeler JM; Knittle JD; Miller JD
    Am J Obstet Gynecol; 1992 Nov; 167(5):1367-71. PubMed ID: 1442992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Add-back therapy in the treatment of endometriosis: the European experience.
    Edmonds DK
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():10-3. PubMed ID: 8916980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
    Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group.
    Wheeler JM; Knittle JD; Miller JD
    Am J Obstet Gynecol; 1993 Jul; 169(1):26-33. PubMed ID: 8333471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back.
    Agarwal SK; Foster WG
    Biomed Res Int; 2015; 2015():878517. PubMed ID: 26247030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
    Surrey ES; Judd HL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms.
    Kaser DJ; Missmer SA; Berry KF; Laufer MR
    J Pediatr Adolesc Gynecol; 2012 Apr; 25(2):105-108. PubMed ID: 22154396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.